% alzhub.org topic: preclinical
% Source: https://alzhub.org/topic/preclinical
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{ravichandran2025-39794837,
  author  = {Ravichandran, S. and Snyder, P. J. and Alber, J. and Murchison, C. F. and Chaby, L. E. and Jeromin, A. and Arthur, E.},
  title   = {{Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01668-5},
  pmid    = {39794837},
  url     = {https://doi.org/10.1186/s13195-024-01668-5}
}

@article{devanarayan2024-38940656,
  author  = {Devanarayan, V. and Doherty, T. and Charil, A. and Sachdev, P. and Ye, Y. and Murali, L. K. and Llano, D. A. and Zhou, J. and others},
  title   = {{Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.14073},
  pmid    = {38940656},
  url     = {https://doi.org/10.1002/alz.14073}
}

@article{salami2022-34924376,
  author  = {Salami, A. and Adolfsson, R. and Andersson, M. and Blennow, K. and Lundquist, A. and Adolfsson, A. N. and Schöll, M. and Zetterberg, H. and others},
  title   = {{Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2022},
  doi     = {10.3233/jad-210673},
  pmid    = {34924376},
  url     = {https://doi.org/10.3233/jad-210673}
}

@article{graurivera2021-33597012,
  author  = {Grau-Rivera, O. and Navalpotro-Gomez, I. and Sánchez-Benavides, G. and Suárez-Calvet, M. and Milà-Alomà, M. and Arenaza-Urquijo, E. M. and Salvadó, G. and Sala-Vila, A. and others},
  title   = {{Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00781-z},
  pmid    = {33597012},
  url     = {https://doi.org/10.1186/s13195-021-00781-z}
}

@article{keshavan2021-33598527,
  author  = {Keshavan, A. and Wellington, H. and Chen, Z. and Khatun, A. and Chapman, M. and Hart, M. and Cash, D. M. and Coath, W. and others},
  title   = {{Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2021},
  doi     = {10.1002/dad2.12131},
  pmid    = {33598527},
  url     = {https://doi.org/10.1002/dad2.12131}
}

@article{adamczuk2015-26677842,
  author  = {Adamczuk, K. and Schaeverbeke, J. and Vanderstichele, H. M. and Lilja, J. and Nelissen, N. and Van Laere, K. and Dupont, P. and Hilven, K. and others},
  title   = {{Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0159-5},
  pmid    = {26677842},
  url     = {https://doi.org/10.1186/s13195-015-0159-5}
}